Business, energy, technology, markets and global industry news from Business News Today

Restylane

PharmaDeviceNews Restylane
Galderma’s Restylane Shaype has secured European Union approval for temporary chin augmentation, expanding the company’s high-firmness hyaluronic acid filler portfolio as competition intensifies in facial shaping and injectable aesthetics. Representative image.
Medical Devices & Diagnostics

Restylane Shaype has cleared Europe, but can Galderma turn its “bone-mimicking” filler into a new chin-shaping standard?

Galderma’s Restylane Shaype gains EU MDR approval for chin augmentation, bringing its high-firmness NASHA HD filler into Europe.

Read More
Pharma & Biotech

Galderma backs new evidence for Sculptra and Restylane in fast-evolving patient demand segments

Read how Galderma’s new interim data could influence aesthetic treatment planning in menopause and GLP-1-related volume loss.

Read More
Galderma pivots Restylane campaign toward lifestyle-driven aesthetic trends with new IMCAS data
Pharma & Biotech

How Galderma’s Wake Up To Restylane campaign reflects evolving aesthetics patient preferences

Explore how Galderma’s Wake Up To Restylane strategy and new IMCAS data could reshape aesthetic practice and hyaluronic acid filler adoption.

Read More